Quince Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Quince Therapeutics, Inc. (QNCX) reported Increase (Decrease) in Other Noncurrent Assets of -$165.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-05-10
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2022-03-31 was -$165.00K.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2021-03-31 was $0.00.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2020-12-31 was -$170.00K.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2020-09-30 was -$35.00K, a 1266.67% decline year-over-year.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2021 was $155.00K.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2020 was -$178.00K, a 185.99% decline from fiscal 2019.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2019 was $207.00K.
- Quince Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2018 was -$50.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$165.00K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $155.00K 10-K · filed 2022-03-01 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$170.00K derived: sum of 2 quarters · filed 2022-05-10 | -$205.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$205.00K derived: sum of 2 quarters · filed 2022-03-01 | -$178.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$8.00K 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $27.00K 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | -$46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$43.00K derived: sum of 2 quarters · filed 2022-03-01 | -$43.00K derived: sum of 3 quarters · filed 2022-03-01 | $207.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $3.00K derived: sum of 2 quarters · filed 2020-11-12 | $253.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $250.00K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $250.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | -$50.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |